Artiva Biotherapeutics (ARTV) Treasury Shares (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Treasury Shares of $4.1 million for Q1 2026, down 34.09% year-over-year from $6.2 million in Q1 2025, and up 53.73% quarter-over-quarter from $2.6 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Treasury Shares (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Treasury Shares for 4 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 34.09% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 34.09% YoY), while the FY2025 annual figure was $2.6 million, up 421.07% from the prior year.
- Treasury Shares rose to $4.1 million in Q1 2026 per ARTV's latest filing, from $2.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $6.2 million in Q1 2025 and bottomed at $506845.0 in Q4 2024.
- Historically, Treasury Shares has averaged $3.5 million across 4 years, with a median of $3.7 million in 2023.
- Annual changes were most pronounced in 2024 — Treasury Shares sank 79.62% — and 2025, when it jumped 421.07%.
- Artiva Biotherapeutics' Treasury Shares stood at $2.5 million in 2023, then tumbled by 79.62% to $506845.0 in 2024, then surged by 421.07% to $2.6 million in 2025, then soared by 53.73% to $4.1 million in 2026.
- Business Quant data shows ARTV's Treasury Shares at $4.1 million in Q1 2026, $2.6 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 3.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.71 Mn |
| Jun 30, 2026 | 3.71 Mn |
| Mar 31, 2026 | 4.06 Mn |
| Mar 31, 2026 | 4.06 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Dec 31, 2024 | 506,845.00 |
| Dec 31, 2024 | 506,845.00 |
| Jun 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Dec 31, 2023 | 2.49 Mn |